CompoAtlas

Gemmothérapie Rate Pancreas / Pi complément alimentaire

Food supplement declared in France, declaration No 2020-6-26, decision dated 1 June 2020

Gemmothérapie Rate Pancreas / Pi complément alimentaire (MERYSTEME) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Betula pubescens 287 mg per day, Morus nigra 287 mg per day, Vaccinium myrtillus 287 mg per day, Juglans regia 287 mg per day, Rubus fruticosus 287 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
MERYSTEME
Food business operator placing the product on the market
MERYSTEME
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
30 gouttes
Directions for use
5 à 15 gouttes 2 fois par jour dans un verre d'eau pendant 21 jours
Not recommended (according to the manufacturer)
Allergy to salicylate derivatives, Taking anticoagulants

Declaration 316345, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Betula pubescens Ehrh.BourgeonAutre extrait fluide287 mg
Morus nigra L.Feuille (bourgeon)Autre extrait fluide287 mg
Vaccinium myrtillus L.Jeune pousseAutre extrait fluide287 mg
Juglans regia L.BourgeonAutre extrait fluide287 mg
Rubus fruticosus L.Jeune pousseAutre extrait fluide287 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

L'emploi aux personnes allergiques aux dérivés salicylés et aux personnes sous traitements anticoagulant est déconseillé. Tenir hors de portée des enfants.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Betula pubescens Ehrh.
    Read the warning, when it applies and the studies cited

    Birch

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).

    Sources cited by Health Canada (4)
    • Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 28 August 2024

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : MERYSTEME

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Gemmothérapie Rate Pancreas / Pi complément alimentaire (MERYSTEME): composition and regulation”, https://compoatlas.com/en/supplements/products/316345-gemmotherapie-rate-pancreas-pi-complement-alimentaire, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line